This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
DCP1A · Western blot design guide
DCP1A Western Blot Planning Guide
Plan a DCP1A Western blot around the catalog-observed 63.3 kDa band, image-backed A04587-2 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
DCP1A Western Blot Experimental Design Guide
Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 63.3 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 12-15% | |
| Positive control | Cerebellum | |
| Negative control | Oral mucosa |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 63.3 kDa |
| ⓘ | Localization | Cytoplasm, P-body / Nucleus |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human / Mouse / Rat |
Section 1
Real Curated DCP1A Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Appendix |
| Gel % | 12-15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, standard transfer |
| Membrane | 0.45 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | A04587-2 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected DCP1A Western Blot Band Size?
Use the product-observed 63.3 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 63.3 kDa | Matches the authoritative product WB observation. |
| 63.3 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected DCP1A appearancePlan around 63.3 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 63.3 kDa; use this as the primary experimental expectation. |
| Calculated mass | 63.3 kDa from UniProt Q9NPI6; retain as context. |
| Gel selection | 12-15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with A04587-2. |
| Situation | Likely cause | Next action |
|---|---|---|
| 63.3 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing DCP1A band
A04587-2 · DCP1A
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for DCP1A Western blot
🧪Use Cerebellum as the first positive-control candidate and Oral mucosa as the HPA Not detected negative candidate.
Positive control: Cerebellum (Medium)
Negative control: Oral mucosa (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for DCP1A
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | Reported tissue cells | Medium | Protein (HPA) | HPA → |
| Colon | Reported tissue cells | Medium | Protein (HPA) | HPA → |
| Caudate | Reported tissue cells | Medium | Protein (HPA) | HPA → |
| Appendix | Reported tissue cells | Medium | Protein (HPA) | HPA → |
Section 3
Advanced DCP1A Western Blot Tips
Deeper troubleshooting and optimisation questions for DCP1A, answered from its protein features.
Which band should guide the blot?
Use 63.3 kDa, the observation attached to the authoritative A04587-2 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 63.3 kDa expectation.
Which positive control should I start with?
Start with Cerebellum, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Oral mucosa as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for DCP1A Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A04587-2 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents
DCP1A Western Blot Reagents
Human/Mouse/Rat-reactive DCP1A Western blot reagents with authoritative product imagery.
Real WB data
Anti-DCP1A Antibody Picoband®
Cat # A04587-2
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt Q9NPI6
- Human Protein Atlas — DCP1A
- A04587-2 product record
- PMC12701684 — Ras Homolog Enriched in Brain Protein Reverses Amyloid Beta-Induced Escape of Inflammatory Cytokine mRNAs From Immunoisolated RNA Processing Bodies of Glioblastoma Cells (FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025)
- PMC11869656 — The Seneca Valley virus 3C protease cleaves DCP1A to attenuate its antiviral effects (Veterinary research, 2025)
- PMC3630112 — Phosphorylation of mRNA decapping protein Dcp1a by the ERK signaling pathway during early differentiation of 3T3-L1 preadipocytes (PloS one, 2013)